| APC | antigen-presenting cell |
| CAR | chimeric antigen receptor |
| CNI | calineurin inhibitor |
| CTG | cell therapy group |
| CTLA4Ig | cytotoxic T-Lymphocyte-Associated Protein 4 immunoglobulin |
| darTreg | donor-antigen-reactive Treg |
| DSA | donor-specific antibodies |
| EV | extracellular vesicle |
| GMP | good manufacturing practice |
| GvHD | graft-versus-host disease |
| MHC | major histocompatibility complex |
| miRNa | microRNA |
| MS | multiple sclerosis |
| NHP | nonhuman primate |
| Nrp-1 | neuropilin-1 |
| nTreg | natural Treg |
| pTreg | peripheral Treg |
| RGT | reference group trial |
| SOT | solid organ transplantation |
| T1D | type 1 diabetes |
| TCR | T-cell receptor |
| TDSR | Treg-specific demethylated region |
| Tregs | regulatory T cells |
| tTreg | thymic Treg |